House Approves NCI’s First $4 Billion Budget, $22.8 Billion For NIH In FY2002.
Foundation Honors Three In Oncology; Society Wins Software Grant From Microsoft.
Arthur James, Ohio Founder Of Research Institute, Dead.
Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.
Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s.
Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit.
Trending Stories
- Preparing to take care of each other in ways we never imagined
- 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
- From the chairs of ECOG-ACRIN: A perspective on indirect costs
- On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers
The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns”